Loading…
Based on limited metadata, this Warning Letter was issued to Fenwal International, Inc., a company involved in biologic products, on June 14, 2020. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The letter falls under FDA's biologics regulatory oversight, though the specific issuing office is not identified in the metadata provided. To understand the substantive compliance issues cited, the complete Warning Letter would need to be reviewed.